FindTrial
Sign In

Preliminary Exploration of the Effectiveness and Safety of Remimazolam for dental comfort Treatment in patients of different ages

Preliminary Exploration of the Effectiveness and Safety of Remimazolam for dental comfort Treatment in patients of different ages

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113172
Enrollment
Unknown
Registered
2025-11-25
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental anxiety

Interventions

Study 3: Young Adult Group (Y Group: 18-44 years old), Middle-Aged Group (M Group: 45-59 years old), Young-Old Group (YO Group: 60-74 years old), and Older Adult Group (O Group: 75-89 years old):Admin
Study 1:Youth group (Y group: 18-44 years old), middle-aged group (M group: 45-59 years old), young elderly group (YO group: 60-74 years old), and elderly group (O group: 75-89 years old):Administerin
Study 2: Young adult group (Y group: 18-44 years old), middle-aged group (M group: 45-59 years old), younger elderly group (YO group: 60-74 years old), and elderly group (O group: 75-89 years old):Adm

Sponsors

Beijing Stomatological Hospital , Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1.ASA I or II; 2.patients of either sex; 3.body mass index of 18.5-23.9kg/m^2;

Exclusion criteria

Exclusion criteria: 1.patients who suffering from hearing impairment; 2.patients who had a history of dependence on benzodiazepines or alcohol abuse; 3.patients who had a documented allergy or medical contraindication to benzodiazepines; 4.patients who suffering from mental illness or cognitive dysfunction; 5.patients who refuse to participate or request to withdraw during the research process; 6.Pregnant or lactating women;

Design outcomes

Primary

MeasureTime frame
Study 1: Sedation Success Rate of Remimazolam;Study Three: Effectiveness;The success rate of falling asleep with Remimazolam;—

Secondary

MeasureTime frame
Study Three:Safety;Study One:Mean Arterial Pressure,Heart Rate,Respiratory Rate,Saturation of peripheral oxygen,Bispectral Index;Study Two:Mean Arterial Pressure,Heart Rate,Respiratory Rate,Saturation of peripheral oxygen,Bispectral Index;Study 3: Onset Time of Sedation;Study 3: Awakening Time;Study 3: Visual Analog Scale (VAS) Pain Score;Study 3: Time of Discharge;Study 3: Incidence of Intraoperative Adverse Reactions;Study 3: Patient Satisfaction;Study 3: Vital Signs;—

Countries

China

Contacts

Public ContactYan Huiyu;Wu Anshi

Beijing Stomatological Hospital , Capital Medical University

yhybjkqyy@163.com+86 10 57099158

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026